UPDATE : Monday, September 16, 2019
상단여백
Invossa victims, Kolon shareholders demand apology, compensation
After the Korea Exchange’s Corporate Review Committee decided to delist Kol...
by Jeong Sae-im  |  2019-08-27 15:40
라인
HLB to test rivoceranib+Lonsurf in colon cancer
HLB said it would test a combination therapy using rivoceranib with Lonsurf...
by Jeong Sae-im  |  2019-08-27 15:39
라인
Regulator decides to delist Kolon TissueGene
Kolon TissueGene, an affiliate of Kolon Life Science, is on the verge of be...
by Jeong Sae-im  |  2019-08-27 12:15
라인
Possibility proved to use AI in sleep staging classification
Korean researchers have developed an algorithm to identify wakefulness and ...
by Choi Gwang-seok  |  2019-08-26 17:03
라인
Temple stay beneficial to mental health, SNUH says
The temple stay program, or a retreat program to practice Buddhist meditati...
by Choi Gwang-seok  |  2019-08-26 15:01
라인
'Myongji Hospital to change concept of sports medicine in Korea’
Myongji Hospital is making strides to transform itself into the best sports...
by Lee Han-soo  |  2019-08-26 11:43
라인
Pharmaceutical sector’s job growth twice of all industries’ average
The pharmaceutical industry’s employment growth rate was eight times higher...
by Jeong Sae-im  |  2019-08-26 11:39
라인
Invossa still effective despite mislabeling, maker claims
Kolon Life Science said that U.S. orthopedic surgeons had published a resea...
by Lee Han-soo  |  2019-08-23 20:16
라인
Medipost’s Pneumostem gets FDA’s fast-track designation
Medipost said that the U.S. Food and Drug Administration has given a fast- ...
by Lee Han-soo  |  2019-08-23 17:51
라인
Vivozon finishes P3 trial for nonnarcotic analgesics
Vivozon, a local biopharmaceutical company, said Friday that it has complet...
by Lee Han-soo  |  2019-08-23 16:03
라인
49 international healthcare experts receive Korean medical training
Forty-nine healthcare professionals from 10 countries have come to Korea to...
by Choi Gwang-seok  |  2019-08-23 16:02
라인
'Surgery more viable option for gastroesophageal reflux disease'
A research team at Chung-Ang University Hospital (CUH) has proved that surg...
by Lee Han-soo  |  2019-08-23 15:02
라인
HLB wins FDA nod for P2 trial on rivoceranib in adenoid cystic carcinoma
HLB said Thursday it has obtained approval from the U.S. Food and Drug Admi...
by Jeong Sae-im  |  2019-08-23 15:02
라인
Ministry OKs P1 trial into Haim Bio’s metabolism anticancer drug
Haim Bio said that the Ministry of Food and Drug Safety has approved its in...
by Lee Han-soo  |  2019-08-23 13:53
라인
GenNBio to test transplanting pig’s pancreatic islet into human next year
GenNBio said it would officially enter the market of transplanting organs f...
by Jeong Sae-im  |  2019-08-23 13:53
라인
'Peptron's Parkinson's disease treatment blocks levodopa side effects'
Peptron said it has confirmed that PT320, a Parkinson's disease treatme...
by Lee Han-soo  |  2019-08-22 17:53
라인
Japan gives further nod to Celltrion's breast cancer biosimilar
Celltrion Healthcare said that Japan's Ministry of Health, Labour and W...
by Lee Han-soo  |  2019-08-22 16:47
라인
‘Drug firm’s pick of doctor to attend conference overseas illegal’
Pharmaceutical companies’ support for physicians to attend academic confere...
by Kim Yun-mi  |  2019-08-22 15:45
라인
SK Biopharmaceutical’s sleepiness drug initially aimed to treat depression
Sunosi (ingredient: solriamfetol), a treatment for narcolepsy developed by ...
by Lee Hye-seon  |  2019-08-22 15:37
라인
Tego Science’s diabetic foot ulcer treatment gets insurance benefit
Tego Science said that Kaloderm, a homologous cell-based drug, will receive...
by Lee Han-soo  |  2019-08-22 15:34
여백
여백
여백
Back to Top